Man Group
GH icon

Man Group’s Guardant Health GH Stock Holding History

Man Group’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.69M Buy
17,949
+8,266
+85% +$899K ﹤0.01% 1428
2026
Q1 		$894K Sell
9,683
-286,121
-97% -$28.7M ﹤0.01% 1874
2025
Q4 		$30.2M Sell
295,804
-455,729
-61% -$40.8M 0.05% 361
2025
Q3 		$47M Sell
751,533
-54,539
-7% -$2.97M 0.08% 273
2025
Q2 		$41.9M Buy
806,072
+739,800
+1,116% +$33M 0.08% 278
2025
Q1 		$2.82M Sell
66,272
-859,036
-93% -$37.1M 0.01% 1232
2024
Q4 		$28.3M Sell
925,308
-95,402
-9% -$2.68M 0.07% 314
2024
Q3 		$23.4M Buy
+1,020,710
New +$28.9M 0.06% 402
2024
Q2 		– Sell
-971,353
Closed -$20M – 2104
2024
Q1 		$20M Sell
971,353
-36,693
-4% -$787K 0.05% 428
2023
Q4 		$27.3M Buy
+1,008,046
New +$26.4M 0.08% 302
2023
Q3 		– Sell
-15,715
Closed -$553K – 417
2023
Q2 		$563K Buy
+15,715
New +$451K ﹤0.01% 1553
2023
Q1 		– Hold
0
– – – 877
2022
Q2 		– Sell
-35,494
Closed -$1.76M – 738
2022
Q1 		$2.35M Buy
+35,494
New +$2.43M 0.01% 1172
2021
Q4 		– Sell
-22,794
Closed -$2.85M – 2004
2021
Q3 		$2.85M Sell
22,794
-17,878
-44% -$2.12M 0.01% 1068
2021
Q2 		$5.05M Sell
40,672
-10,832
-21% -$1.46M 0.02% 883
2021
Q1 		$7.86M Buy
51,504
+3,698
+8% +$559K 0.03% 505
2020
Q4 		$6.16M Buy
47,806
+13,422
+39% +$1.54M 0.03% 690
2020
Q3 		$3.84M Sell
34,384
-10,644
-24% -$974K 0.02% 939
2020
Q2 		$3.65M Buy
45,028
+40,599
+917% +$3.27M 0.02% 808
2020
Q1 		$308K Buy
+4,429
New +$340K ﹤0.01% 1381
2019
Q4 		– Sell
-7,630
Closed -$488K – 1858
2019
Q3 		$488K Buy
7,630
+2,066
+37% +$182K ﹤0.01% 1583
2019
Q2 		$480K Sell
5,564
-3,054
-35% -$233K ﹤0.01% 1674
2019
Q1 		$661K Buy
+8,618
New +$478K ﹤0.01% 1679

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Man Group's GH Position: Q2 2026 in Review

Man Group increased its Guardant Health (GH) stake by 85% in Q2 2026, buying an estimated $899K and bringing the position to 17,949 shares worth $2.69M. The position accounts for ﹤0.01% of the portfolio, ranked #1428.

Man Group first reported a position in GH in Q1 2019 and has held it in 22 quarters since. The position peaked at $47M in Q3 2025. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Man Group held 17,949 shares of Guardant Health worth $2.69M as of Q2 2026.
  • Man Group bought 8,266 Guardant Health shares in Q2 2026, an estimated $899K.
  • Guardant Health made up ﹤0.01% of Man Group's portfolio in Q2 2026, its #1428 holding.
  • Man Group first reported a position in Guardant Health in Q1 2019 and has held it in 22 quarters since.
  • Man Group's Guardant Health position peaked at $47M in Q3 2025.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.